[Psoriasis and cardiovascular risk factors]

Harefuah. 2012 Oct;151(10):573-5, 605.
[Article in Hebrew]

Abstract

Psoriasis is a common inflammatory skin disease which may dramatically affect patients' lives. This chronic disease is characterized by a protracted course of alternating remissions and relapses. In recent years, the attention of researchers has focused on the association between psoriasis and cardiovascular disease risk factors. This review summarizes the literature on this topic with an emphasis on research conducted in Israel.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Cardiovascular Diseases* / epidemiology
  • Cardiovascular Diseases* / etiology
  • Cardiovascular Diseases* / metabolism
  • Cardiovascular Diseases* / physiopathology
  • Cardiovascular System / drug effects
  • Cardiovascular System / metabolism
  • Cardiovascular System / physiopathology
  • Chronic Disease
  • Health Status Disparities
  • Humans
  • Immunotherapy / adverse effects
  • Immunotherapy / methods
  • Inflammation* / metabolism
  • Inflammation* / physiopathology
  • Interleukin-6 / metabolism
  • Israel / epidemiology
  • Psoriasis* / complications
  • Psoriasis* / epidemiology
  • Psoriasis* / metabolism
  • Psoriasis* / physiopathology
  • Psoriasis* / therapy
  • Research
  • Risk Factors
  • Skin / metabolism
  • Skin / physiopathology
  • Tumor Necrosis Factors / metabolism
  • Ultraviolet Therapy / adverse effects
  • Ultraviolet Therapy / methods

Substances

  • Interleukin-6
  • Tumor Necrosis Factors